Clinical Characteristics and Medical Care Situation of Ischemic Stroke in Children in China

doi:10.3969/j.issn.1673-5765.2021.08.011

Abstract

Abstract: Objective To investigate the clinical presentation, risk factors, causes and medical care situation of ischemic stroke in children in China. Methods The data of inpatients with ischemic stroke aged from 1 month to 18 years from hospitals in Beijing (excluding army hospital) from January 2018 to December 2018 were retrospectively analyzed. The clinical information included demographics, clinical presentation, risk factors, examination results, complications after admission, treatment in acute phase, secondary prevention and neurologic deficits at discharge. Results A total of 172 children patients were included, with a median age of 9.0 years old (range: 6.0-11.2 years old) and 103 boys (59.88%). The proportion of patients aged 7-10 years old and aged over 10 years old were relatively high, 34.30% and 31.40%, respectively. The most common clinical symptom was hemiplegia (n =160, 93.02%), the next one was speech disturbance (n =43, 25.00%), and the other symptoms included consciousness disturbance and headache. In

addition, 29 patients (16.86%) had seizure. 159 patients (92.44%) had at least one risk factor, and

cerebrovascular disease was the main cause (n =133, 77.3%), among which the most common was Moyamoya disease (n =118, 68.60%), 14 patients (8.14%) had heart disease and no clear causes were found in 13 patients (7.56%). 30 patients (17.44%) received antithrombotic therapy, and 9 patients (5.23%) received anticoagulant therapy in the acute phase. 11 patients (6.40%) received antithrombotic therapy, and 2 patients (1.16%) received anticoagulant therapy for secondary prevention at discharge. Conclusions The peak onset of ischemic stroke in children is 7-10 years old. Hemiplegia is the most common clinical presentation, and the main cause of ischemic stroke is Moyamoya disease. Antithrombotic therapy was insufficient in acute phase and secondary prevention for ischemic stroke children.

Key words: Ischemic stroke; Risk factor; Children; Treatment

摘要： 目的分析儿童缺血性卒中的临床表现、危险因素、病因及诊疗现状。方法通过检索北京市出院病案首页，连续纳入2018年1-12月住院的缺血性卒中儿童患者，收集并分析患儿人口学信息、临床表现、卒中危险因素、实验室检查及辅助检查结果、入院后并发症、急性期治疗及出院时二级预防措施、出院时神经功能缺损情况。结果研究共纳入172例缺血性卒中患儿，男性103例（59.88%），女性69例（40.12%）。中位发病年龄为9.0（6.0～11.2）岁，7～10岁和＞10岁患儿比例较高，分别为34.30%和31.40%。最常见症状为偏瘫（160例，93.02%），其次为构音障碍（43例，25.00%），全脑症状包括意识水平下降和头痛，另外，29例（16.86%）患儿有癫痫发作。159例（92.44%）患儿至少发现一种危险因素，脑血管病变为主要病因（133例，77.33%），其中最常见的为烟雾病（118例，68.60%）；14例（8.14%）患儿有心脏疾病； 13例（7.56%）患者未找到明确病因。急性期接受抗血小板治疗者30例（17.44%），抗凝治疗者9例（5.23%）；出院时二级预防措施中仅11例（6.40%）接受抗血小板治疗，2例（1.16%）接受抗凝治疗。结论该组儿童缺血性卒中病例发病高峰是学龄期，肢体瘫痪为最常见的临床表现，烟雾病是主要病因。缺血性卒中患儿急性期及二级预防的抗血栓治疗均明显不足。

关键词: 缺血性卒中; 危险因素; 儿童; 治疗

DENG Ya-Xian, ZHANG Gui-Tao, WANG Lei, YAO Chun-Mei, XU Juan-Yu, LIU Gai-Fen, ZHAO Cheng-Song. Clinical Characteristics and Medical Care Situation of Ischemic Stroke in Children in China[J]. Chinese Journal of Stroke, 2021, 16(08): 816-821.

邓亚仙, 张贵涛, 王蕾, 姚春美, 徐娟玉, 刘改芬, 赵成松. 儿童缺血性卒中的临床特点及诊疗现状研究[J]. 中国卒中杂志, 2021, 16(08): 816-821.

References

[1] FERRIERO D M，FULLERTON H J，BERNARD
T J，et al. Management of stroke in neonates and
children：a scientific statement from the American
Heart Association/American Stroke Association[J/
OL]. Stroke，2019，50（3）：e51-e96[2021-02-24].
https：//doi.org/10.1161/str.0000000000000183.
[2] LEHMAN L L，KHOURY J C，TAYLOR J M，et
al. Pediatric stroke rates over 17 years：report from a
population-based study[J]. J Child Neurol，2018，33
（7）：463-467.
[3] 王佳，张东，王嵘，等. 儿童烟雾病脑梗死影响因素
分析[J]. 中国卒中杂志，2017，12（9）：817-821.
[4] 宋晓雯，张谦，赵继宗. 烟雾病流行病学研究进
展[J/OL]. 中华脑血管病杂志（电子版），2021，15
（1）：9-15[2021-02-24]. DOI：10.11817/j.issn.1673-
9248.2021.01.002. https：//zhnxgbzz.cma-cmc.com.
cn/CN/10.11817/j.issn.1673-9248.2021.01.002.
[5] AGRAWAL N，JOHNSTON S C，WU Y W，et
al. Imaging data reveal a higher pediatric stroke
incidence than prior us estimates[J]. Stroke，2009，
40（11）：3415-3421.
[6] GANESAN V，HOGAN A，SHACK N，et al.
Outcome after ischaemic stroke in childhood[J]. Dev

Med Child Neurol，2000，42（7）：455-461.

[7] DARTEYRE S，CHABRIER S，PRESLES E，et
al. Lack of progressive arteriopathy and stroke
recurrence among children with cryptogenic
stroke[J]. Neurology，2012，79（24）：2342-2348.
[8] SACCO R L，KASNER S E，BRODERICK J P，et
al. An updated definition of stroke for the 21st
century：a statement for healthcare professionals
from the American Heart Association/American
Stroke Association[J]. Stroke，2013，44（7）：2064-
2089.
[9] BHOGAL P，ANDERSSON T，MAUS V，et al.
Mechanical thrombectomy-a brief review of a
revolutionary new treatment for thromboembolic
stroke[J]. Clin Neuroradiol，2018，28（3）：313-326.
[10] BIGI S，DULCEY A，GRALLA J，et al. Feasibility，
safety，and outcome of recanalization treatment
in childhood stroke[J]. Ann Neurol，2018，83（6）：
1125-1132.
[11] BONFERT M V，BADURA K，GERSTL J，et
al. Childhood stroke：awareness，interest，and
knowledge among the pediatric community[J/OL].
Front Pediatri，2018，6：182[2021-02-24]. https：//doi.
org/10.3389/fped.2018.00182.
[12] MALLICK A A，GANESAN V，KIRKHAM，et al.
Diagnostic delays in paediatric stroke[J]. J Neurol
Neurosurg Psychiatry，2015，86（8）：917-921.
[13] SARECKA-HUJAR B，KOPYTA I. Risk factors for
recurrent arterial ischemic stroke in children and
young adults[J]. Brain sci，2020，10（1）：24.
[14] FULLERTON H J，WINTERMARK M，HILLS N
K，et al. Risk of recurrent arterial ischemic stroke
in childhood：a prospective international study[J].
Stroke，2016，47（1）：53-59.
[15] STUDER M，BOLTSHAUSER E，CAPONE MORI
A，et al. Factors affecting cognitive outcome in early
pediatric stroke[J]. Neurology，2014，82（9）：784-
792.
[16] MALLICK A A，GANESAN V，KIRKHAM F J，et
al. Outcome and recurrence 1 year after pediatric
arterial ischemic stroke in a population-based
cohort[J]. Ann Neurol，2016，79（5）：784-793.
[17] LEHMAN L L，MALETSKY K，BEAUTE J，et al.
Prevalence of symptoms of anxiety，depression，and
post-traumatic stress disorder in parents and children
following pediatric stroke[J]. J Child Neurol，2020，
35（7）：472-479.
[18] RENNIE A. Endovascular clot retrieval for acute
ischaemic posterior circulation stroke in children：a
new effective therapy?[J]. Dev Med Child Neurol，
2020，62（10）：1119-1120.
[19] SUN L R，FELLING R J，PEARL M S.
Endovascular mechanical thrombectomy for acute
stroke in young children[J]. J Neurointerv Surg，
2019，11（6）：554-558.
[20] JIMENEZ GOMEZ E，BRAVO REY I，OTEROS
FERNANDEZ R，et al. Endovascular treatment of
stroke in children under 2 years with heart failure
and ventricular assist device[J]. Interv Neuroradiol，
2019，25（5）：516-520.
[21] MONAGLE P，CHALMERS E，CHAN A，et
al. Antithrombotic therapy in neonates and
children：American College of Chest physicians
evidence-based clinical practice guidelines（8th
edition）[J/OL]. Chest，2008，133（6 Suppl）：
887S-968S[2021-02-24]. https：//doi.org/10.1378/
chest.08-0762.
[22] ROACH E S，GOLOMB M R，ADAMS R，et al.
Management of stroke in infants and children：a
scientific statement from a special writing group of
the American Heart Association stroke council and
the council on cardiovascular disease in the young[J].
Stroke，2008，39（9）：2644-2691.
[23] MEDLEY T L，MITEFF C，ANDREWS I，et
al. Australian clinical consensus guideline：the
diagnosis and acute management of childhood
stroke[J]. Int J Stroke，2019，14（1）：94-106.
[24] GERSTL L，WEINBERGER R，HEINEN F，et al.
Arterial ischemic stroke in infants，children，and
adolescents：results of a Germany-wide surveillance
study 2015-2017[J]. J Neurol，2019，266（12）：2929-
2941.
[25] LYLE C A，BERNARD T J，GOLDENBERG N
A. Childhood arterial ischemic stroke：a review of
etiologies，antithrombotic treatments，prognostic
factors，and priorities for future research[J]. Semin
Thromb Hemost，2011，37（7）：786-793.